SCHEMBL7784247

SCHEMBL7784247

CCOC(=O)CNc1cc(Cl)c(CC)cc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.60
MAPT P10636 5/20 0.46
KDM4E B2RXH2 2/20 0.46
GLA P06280 1/20 0.45
BCL6 P41182 1/20 0.45
BCOR Q6W2J9 1/20 0.45
ALDH1A1 P00352 5/20 0.44
RAB9A P51151 2/20 0.44
PKM P14618 2/20 0.44
NPC1 O15118 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
MAPK1 P28482 2/20 0.43
GAA P10253 1/20 0.43
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42
PTGER4 P35408 1/20 0.41
POLB P06746 2/20 0.41
GALR2 O43603 1/20 0.41
MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8191379 0.84 LMNA (0.59) LMNAMAPTKDM4EGLABCL6
SCHEMBL8607862 0.81 LMNA (0.72) LMNAMAPTKDM4EALDH1A1RAB9A
SCHEMBL26841476 0.81 LMNA (0.61) LMNAMAPTKDM4EGLAALDH1A1
SCHEMBL8190013 0.81 LMNA (0.64) LMNAMAPTKDM4EGLAALDH1A1
SCHEMBL9863059 0.80 LMNA (0.62) LMNAMAPTKDM4EGLABCL6
SCHEMBL8194578 0.79 LMNA (0.61) LMNAMAPTKDM4EGLAALDH1A1
SCHEMBL16122493 0.78 L3MBTL1 (0.47) LMNAMAPTKDM4EGLAALDH1A1
SCHEMBL7784830 0.78 HCAR3 (0.40) LMNAMAPTBCL6BCORALDH1A1
SCHEMBL7784833 0.78 ALDH1A1 (0.46) LMNAMAPTBCL6BCORALDH1A1
SCHEMBL27461074 0.78 LMNA (0.55) LMNAMAPTKDM4EGLABCL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed